CONSTELLATION PHARMACEUTICALS CEO Jigar Raythatha's 2018 pay jumps 56% to $4.7M
CONSTELLATION PHARMACEUTICALS reports 2018 executive compensation
By ExecPay News
Published: April 26, 2019
CONSTELLATION PHARMACEUTICALS reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, three executives at CONSTELLATION PHARMACEUTICALS received on average a compensation package of $2.4M, a 36% increase compared to previous year.
Average pay of disclosed executives at CONSTELLATION PHARMACEUTICALS
Jigar Raythatha, Chief Executive Officer, received $4.7M in total, which increased by 56% compared to 2017. 86% of Raythatha's compensation, or $4.1M, was in option awards. Raythatha also received $203K in bonus, $428K in salary, as well as $6.6K in other compensation.
Emma Reeve, Chief Financial Officer, received a compensation package of $1.4M, which increased by 78% compared to previous year. 55% of the compensation package, or $797K, was in option awards.
Adrian Senderowicz, Chief Medical Officer, earned $1.1M in 2018, a 26% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2019.